Abrysvo
(Respiratory Syncytial Virus Vaccine)Pfizer Laboratories Div Pfizer Inc
Usage: ABRYSVO is a vaccine indicated for active immunization against lower respiratory tract disease (LRTD) caused by RSV. It is for pregnant individuals (32-36 weeks gestation), individuals 60 years and older, and adults 18-59 years at increased risk for RSV-related LRTD.